New hope for short stature: experimental growth hormone drug enters human trials
NCT ID NCT07450001
First seen Mar 26, 2026 · Last updated Jun 22, 2026 · Updated 18 times
Summary
This study tests a new medicine called GenSci134 in 128 children with growth hormone deficiency, a condition where the body doesn't make enough growth hormone, leading to slow growth. The study has two parts: first, a small group will get a single dose to check safety; second, a larger group will get multiple doses over time to see if it helps them grow taller compared to a standard treatment. The goal is to find the right dose and confirm it works well enough for a larger future study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC GROWTH HORMONE DEFICIENCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, 430000, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.